Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro
about
In vitro and in vivo evaluations of sodium lauryl sulfate and dextran sulfate as microbicides against herpes simplex and human immunodeficiency virusesPathogenesis of human immunodeficiency virus infectionSulfation of the human immunodeficiency virus envelope glycoproteinAnti-HIV-1 activity of anionic polymers: a comparative study of candidate microbicides.Cellulose acetate phthalate, a common pharmaceutical excipient, inactivates HIV-1 and blocks the coreceptor binding site on the virus envelope glycoprotein gp120Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusionPotent and selective inhibition of human immunodeficiency virus (HIV)-1 and HIV-2 replication by a class of bicyclams interacting with a viral uncoating eventAlpha-(1-3)- and alpha-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitroIn vitro inhibition of the infectivity and replication of human immunodeficiency virus type 1 by combination of antiretroviral 2',3'-dideoxynucleosides and virus-binding inhibitorsDifferential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteinsInhibition of human immunodeficiency virus type 1 RNase H by sulfated polyanionsSpecific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infectionsInhibition of gp120-CD4 interaction and human immunodeficiency virus type 1 infection in vitro by pyridoxal 5'-phosphateInhibition of human immunodeficiency virus type 1 infection and syncytium formation in human cells by V3 loop synthetic peptides from gp120Infection by HIV-1 blocked by binding of dextrin 2-sulphate to the cell surface of activated human peripheral blood mononuclear cells and cultured T-cellsHighly potent and selective inhibition of human immunodeficiency virus by the bicyclam derivative JM3100Amphotericin B derivative blocks human immunodeficiency virus type 1 entry after CD4 binding: effect on virus-cell fusion but not on cell-cell fusionCharacterization of human immunodeficiency virus type 1 resistant to modified cyclodextrin sulphate (mCDS71) in vitroThe molecular target of bicyclams, potent inhibitors of human immunodeficiency virus replicationAnti-human immunodeficiency virus type 1 activity of an oligocationic compound mediated via gp120 V3 interactionsMechanism of selective inhibition of human immunodeficiency virus by ingenol triacetateT-cell-line-tropic human immunodeficiency virus type 1 that is made resistant to stromal cell-derived factor 1alpha contains mutations in the envelope gp120 but does not show a switch in coreceptor useChemical barriers to human immunodeficiency virus type 1 (HIV-1) infection: retrovirucidal activity of UC781, a thiocarboxanilide nonnucleoside inhibitor of HIV-1 reverse transcriptaseSulfated Glycans and Related Digestive Enzymes in the Zika Virus Infectivity: Potential Mechanisms of Virus-Host Interaction and Perspectives in Drug DiscoveryTargeting of HIV gp120 by oligonucleotide-photosensitizer conjugates. Light-induced damages.In vitro anti-coxsackievirus B(3) effect of ethyl acetate extract of Tian-hua-fen.Simple assay to screen for inhibitors of interaction between the human immunodeficiency virus envelope glycoprotein and its cellular receptor, CD4Anti-herpes simplex virus activities of two novel disulphated cyclitols.Pharmacokinetics, toxicity, and activity of intravenous dextran sulfate in human immunodeficiency virus infection.Candidate polyanionic microbicides inhibit human T-cell lymphotropic virus type 1 receptor interactions, cell-free infection, and cell-cell spread.Peptides derived from HIV-1 integrase that bind Rev stimulate viral genome integration.Designing anti-influenza aptamers: novel quantitative structure activity relationship approach gives insights into aptamer-virus interactionSulfated polysaccharides and a synthetic sulfated polymer are potent inhibitors of Chlamydia trachomatis infectivity in vitro but lack protective efficacy in an in vivo murine model of chlamydial genital tract infection.Specific interaction of aurintricarboxylic acid with the human immunodeficiency virus/CD4 cell receptor.A styrene-alt-maleic acid copolymer is an effective inhibitor of R5 and X4 human immunodeficiency virus type 1 infection.Polyanions--a lost chance in the fight against HIV and other virus diseases?Innate defences against viraemia.A tight-binding mode of inhibition is essential for anti-human immunodeficiency virus type 1 virucidal activity of nonnucleoside reverse transcriptase inhibitors.env chimeric virus technology for evaluating human immunodeficiency virus susceptibility to entry inhibitors.
P2860
Q24552626-C83C4BA9-08C8-4B93-AF8E-C19925BA84B4Q24634681-01C633B2-8A12-4A02-BC0A-1174B790BF36Q24647955-6F4C92CD-A4AA-4DAE-9974-3387D8853519Q24794033-D4C4AB95-DD16-4DFC-9CEC-5E08F124F4B0Q24806134-6399A626-DDFF-4CE4-A18B-75A11BA5BBAFQ28316430-204F71BD-79F7-4958-A0E3-2132CF0A7FADQ28320362-BDBE21E7-B4A0-44C7-A21D-64A9857E83F9Q28321244-22F487E9-4DCB-4F26-AFD2-DF74F5956C83Q28323307-DCDDC81D-F394-4DE0-B759-A915773587C2Q28324290-83C64723-3B4B-4A67-A514-0C89CCAD3508Q28340338-9D20F3A8-CBA5-4306-AA96-B9231A84CF11Q28344310-A2AB6C15-5F98-4E2A-8570-5AFD7249FA0BQ28362129-D477E7FD-51F7-42BC-9886-D40D9DBA87EBQ28367647-593960E4-AB20-411B-BD07-22F3B24EF8FFQ28368050-0B7DCEA5-BE4D-4DCF-B292-DA357D164C82Q28368254-A9E080A8-A83B-4A00-9511-F561C0BE80F9Q28368978-54C5FBA3-32A7-48C8-B507-F152C0961381Q28369127-1BB36B97-3D42-4815-984E-79DA65A2EFB3Q28371764-59B65299-103C-48BC-B57C-DC20486007F9Q28378759-0290EA13-F5BB-4569-91B6-E4AC4F736542Q28378840-D2F7AF55-5AE0-4E14-A159-E18163424664Q28379091-4B533629-CBB7-412F-89A7-C5B35F399998Q28379465-0965A07B-2572-4668-AFAD-6A646FADDF3BQ28379510-3972F269-4E94-450D-BD49-C7EF08747241Q28817653-A145CFCE-BD49-4834-9129-1F0E1C3F6576Q30830795-3196D750-407E-483D-ACBB-21C259126CDFQ33204844-A995EE65-7BE0-4465-BB45-9F3D6C9AC8CBQ33220705-F0030417-2D1E-4C09-898E-7ABCBBE61DDDQ33260475-F1EA4A21-EAAE-4CD0-B79F-02385FE46366Q33377921-83850C37-8F26-4704-B6C1-B8F681D7506DQ33388659-F02846F7-65CD-4620-BA94-31C336111334Q33398037-704992A1-DAAF-4EAC-9999-790E8453E5CAQ33638356-C9103AE3-82FB-442B-B59F-E44B7050191EQ33751875-DE00964F-2791-4475-B8EF-4B31C8ECF3C8Q33854208-7055FACA-4053-4B37-9FA2-C2EF63F6138DQ33889449-9860A077-3211-4A1F-AB05-983A36E47F15Q34009817-48960DCC-B8F5-4DDA-A212-EB21FD7415C0Q34103163-BC3CA363-C14E-4D95-8B88-6666B5A3E040Q34108974-FF9E1770-4351-4501-83F1-D309332E8550Q34253200-96D4A0C5-0A9A-4887-B616-FB9E4D526333
P2860
Mechanism of inhibitory effect of dextran sulfate and heparin on replication of human immunodeficiency virus in vitro
description
1988 nî lūn-bûn
@nan
1988 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1988 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
name
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@ast
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@en
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@nl
type
label
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@ast
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@en
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@nl
prefLabel
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@ast
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@en
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@nl
P2093
P2860
P356
P1476
Mechanism of inhibitory effect ...... mmunodeficiency virus in vitro
@en
P2093
P2860
P304
P356
10.1073/PNAS.85.16.6132
P407
P577
1988-08-01T00:00:00Z